SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Company issued 484,782.601 Class I shares for approximately $12.042 million pursuant to a continuous private offering under Section 4(a)(2) and Regulation D to accredited investors, representing material equity dilution and capital raising activity.
View raw filing on EDGAR →FuelCell Energy filed a prospectus supplement to its automatic shelf registration statement on Form S-3, indicating a registered offering of securities. The filing of a prospectus supplement with a legal opinion on the issuance and sale of securities is the standard disclosure mechanism for equity or convertible offerings under a shelf registration, which typically results in dilution to existing shareholders. This is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →AB Private Lending Fund completed an unregistered private placement of 9,314 Class I common shares of beneficial interest to feeder vehicles, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →The fund conducted an unregistered private placement of 8,190,511 LLC interests for $211.6 million pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions, raising material capital and diluting existing investors.
View raw filing on EDGAR →Goldman Sachs Private Credit Corp. completed an unregistered sale of 6,097,725 Class I shares and 18,109 Class S shares totaling approximately $150.3 million. The sale was exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S, with purchasers required to be accredited investors or non-U.S. persons.
View raw filing on EDGAR →EQT Private Equity Company LLC completed an unregistered sale of approximately 1.09 million shares across multiple share classes to third-party investors for aggregate cash consideration of $29.45 million as of July 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions, with cumulative sales of $817.6 million since inception.
View raw filing on EDGAR →EQT Infrastructure Company LLC completed an unregistered sale of approximately 3.9 million equity shares across multiple classes to third-party investors for aggregate consideration of $106.2 million as of July 1, 2026, under Section 4(a)(2) and Regulations D and S. Since inception on February 1, 2026, the Company has sold approximately $817.6 million of Investor Shares as part of its continuous private offering.
View raw filing on EDGAR →Nuburu closed a $38.0 million public offering on July 17, 2026, issuing 117.4 million shares of common stock, 127.0 million pre-funded warrants, and 733,853 shares of Series B Preferred Stock convertible into 205.6 million additional common shares. The offering materially dilutes existing shareholders' ownership and voting power, with proceeds intended for the Tekne acquisition and debt retirement.
View raw filing on EDGAR →Virtuix amended three warrants to reduce the exercise price from $3.00 to $2.50 per share during a specified period (July 21 – August 27, 2026), making the warrants more likely to be exercised and diluting existing shareholders. While technically an amendment to existing warrants rather than a new issuance, the material reduction in exercise price substantially increases the probability of dilution and is economically equivalent to a dilutive capital event. The filing under Item 1.01 (Material Definitive Agreement) and the involvement of a significant investor (Streeterville Capital) underscore materiality.
View raw filing on EDGAR →The Company may issue shares of common stock to satisfy a RM2,250,000 (approximately US$550,795.60) deposit obligation under the Share Sale Agreement, with shares calculated based on currency conversion and closing price, subject to a six-month trading restriction under Regulation S.
View raw filing on EDGAR →AMR Resources Acquisition Corp. issued unregistered private placement units simultaneously with the IPO closing: 447,500 Sponsor Private Placement Units ($4.475M) and 260,000 Underwriter Private Placement Units ($2.6M), both pursuant to Section 4(a)(2) exemption. These dilutive private placements materially affect capitalization and investor ownership.
View raw filing on EDGAR →The 6-K discloses completion of a July 2026 offering of 7,975,000 units and 8,525,000 pre-funded units at US$0.40 and US$0.399 per unit respectively, constituting a dilutive equity issuance. The filing explicitly states this July Offering "constitutes a Subsequent Equity Sale under the May Common Warrants," triggering downward adjustment of warrant exercise prices from US$1.30 to US$0.2333 per share—a material anti-dilution event affecting existing warrant holders and demonstrating significant equity dilution to shareholders.
View raw filing on EDGAR →Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $30.1 million in limited partnership units across multiple unit classes (Class S, Class I, Class A-S, and Class A-I) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →The Fund sold 1,203,879 Class I common shares for $32.2 million during July 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, raising material capital through the sale of unregistered securities at NAV pricing.
View raw filing on EDGAR →VisionWave Holdings disclosed an unregistered sale of convertible debentures, warrants, and shares of common stock issuable upon conversion or exercise thereof to an accredited investor in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D, representing a classic private placement with dilutive potential to existing shareholders.
View raw filing on EDGAR →On July 21, 2026, Vivakor issued 33,000 shares to one holder and 32,000 shares to another lender upon conversion of convertible promissory notes with principal and interest totaling approximately $56,225, representing unregistered equity issuances exempt from registration under Section 4(a)(2).
View raw filing on EDGAR →Ares Core Infrastructure Fund sold 45,031,717 common shares for an aggregate purchase price of $1,120.6 million in July 2026 in a private placement exempt from Securities Act registration under Section 4(a)(2) and Regulation D Rule 506(b).
View raw filing on EDGAR →EWSB Bancorp closed a private placement of 88,318 shares of Series A Junior Non-Voting Participating Preferred Stock for $883,180 on July 16, 2026, concluding a rights offering to accredited investors. This is a classic dilutive issuance under Item 3.02 — an unregistered sale of equity securities that increases the company's capitalization and dilutes existing shareholders, particularly material for a small-cap bank raising capital through a preferred equity offering.
View raw filing on EDGAR →SmartKem entered into a Securities Purchase Agreement on March 30, 2026, and amended it on July 16, 2026, to sell Series A convertible preferred stock and warrants to institutional investors. The offering raised approximately $17.1 million and includes warrants to purchase approximately 36.7 million shares of common stock, materially diluting existing shareholders upon conversion and exercise.
View raw filing on EDGAR →The exhibit discloses the exercise of 1,015,511 warrants by Kreos Capital VII Aggregator SCSp, resulting in the issuance of 577,237 new shares through a net exercise mechanism. This represents a dilutive equity issuance tied to a financing arrangement (warrant agreement dated December 23, 2025). The registration of these shares with the Finnish Trade Register increases the total share count from approximately 262.5 million to 263,039,597 shares, materially affecting shareholder ownership percentages and voting power.
View raw filing on EDGAR →Vulcan Infrastructure & Power Inc. completed a $39.4 million PIPE transaction consisting of $29.4 million in Class A common stock issued at $1.71 per share to institutional and insider investors (Machine Investment Group, Atlas Holdings, Conversant Capital), plus a $10 million convertible note and warrants. The company will use proceeds to redeem approximately $33 million of outstanding senior notes due October 2026.
View raw filing on EDGAR →The exhibit discloses a proposed at-the-market (ATM) offering program of up to $200 million in American Depositary Shares (ADSs) representing ordinary shares, filed with the SEC on Form F-3. This is an unregistered equity issuance that will dilute existing shareholders. The announcement explicitly states the Company expects the underlying ordinary shares to represent up to 20% of total issued shares, and the offering is subject to Hong Kong listing rule waivers. This is a material capital-raising event that would affect investor assessment of ownership dilution and the Company's financing strategy.
View raw filing on EDGAR →The 6-K discloses termination of an at-the-market (ATM) offering agreement with AC Sunshine Securities LLC, under which the Company had sold 3,487,171 ordinary shares (approximately 96% of the $200 million authorized offering) as of July 11, 2026. While the termination itself is the headline event, the substance is the dilutive equity issuance that occurred under the ATM program. This represents a material capital-raising activity that would affect a reasonable investor's assessment of share dilution and the Company's financing strategy.
View raw filing on EDGAR →The 6-K discloses entry into a sales agreement on July 20, 2026, authorizing the Company to offer and sell up to $16,000,000 of Class A ordinary shares through an at-the-market (ATM) offering via Craft Capital Management LLC as sales agent. This is a dilutive equity issuance that would materially affect a reasonable investor's assessment of share dilution and capital structure, particularly for a smaller-cap issuer like Linkage Global.
View raw filing on EDGAR →Amesite Inc. entered into an At The Market (ATM) Offering Agreement with H.C. Wainwright & Co. on July 17, 2026, permitting the company to offer and sell shares of common stock up to a maximum aggregate offering price through an ATM mechanism. This is a classic dilutive equity issuance under Rule 415 of the Securities Act, structured as an unregistered or registered direct offering that will dilute existing shareholders. The filing explicitly discloses the 3.0% commission to the agent and the company's intent to use proceeds for general corporate purposes, which is material to investors assessing capital structure and shareholder dilution risk.
View raw filing on EDGAR →Grande Group entered into a Share Purchase Agreement with White Lion Capital on July 16, 2026, granting the Company the right to issue up to 40,000,000 in aggregate gross purchase price of newly issued Class A ordinary shares over 36 months. This is a classic at-the-market (ATM) or equity line of credit arrangement with a pricing mechanism tied to volume-weighted average prices. The registration rights agreement requiring Form F-1/F-3 filing within 30 days confirms intent to register these shares for resale, making this a material dilutive equity issuance that would affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →TOP Financial Group issued 360,534,431 Class A Ordinary Shares resulting from cashless warrant exercise on July 19-20, 2026, relying on Section 3(a)(9) and Section 4(a)(2) exemptions from registration, with shares subject to six-month lockup restrictions.
View raw filing on EDGAR →The company completed a private placement of 645,000 Units to the Sponsor and Underwriter at $10.00 per unit, generating $6.45 million in gross proceeds, pursuant to Section 4(a)(2) exemption, concurrent with the IPO closing.
View raw filing on EDGAR →The filing discloses completion of an IPO of 23,000,000 units at $10.00 per unit generating $230,000,000 in gross proceeds, plus a concurrent private placement of 6,000,000 warrants for $6,000,000. While this is technically an IPO (a public offering), the structure involves unregistered warrant sales to insiders and sponsors, and the company is a blank-check SPAC with no operating business. The material capital raise through equity and warrant issuance fits the dilutive_issuance category, though an IPO completion could also be characterized as operational_other; the warrant component and sponsor involvement support the dilutive classification.
View raw filing on EDGAR →The filing discloses entry into warrant inducement agreements (Item 1.01) and unregistered sales of equity securities (Item 3.02) whereby Laser Photonics issued new Series A-7 and Series A-8 warrants to purchase 5,057,144 shares of common stock in exchange for the exercise of existing warrants, raising approximately $2.5 million in gross proceeds. The new warrants are unregistered and represent a dilutive equity issuance typical of cash-strapped companies raising capital through warrant exercises and inducements.
View raw filing on EDGAR →The Company issued 352,000 shares of common stock in exchange for preferred stock held by an existing investor, relying on Section 3(a)(9) of the Securities Act. This is a dilutive equity issuance to an unaffiliated holder without cash proceeds to the Company. The transaction materially increases common share count and dilutes existing shareholders, which is a hallmark of the dilutive_issuance category.
View raw filing on EDGAR →The filing discloses an unregistered sale of 4,805,778 Class L common shares for $70 million on July 1, 2026, made pursuant to Section 4(a)(2) and Regulation D exemptions to accredited investors and qualified purchasers. This is a classic dilutive private placement of equity securities that would materially affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →Sunshine Biopharma entered into an At-The-Market (ATM) Issuance Sales Agreement on July 20, 2026, authorizing the sale of up to $4,000,000 in common stock shares through Aegis Capital Corp. ATM offerings are unregistered equity issuances that create dilution to existing shareholders and are a material capital-raising mechanism, particularly for smaller biotech companies. The filing explicitly discloses this under Item 1.01 (Entry into a Material Definitive Agreement), confirming materiality.
View raw filing on EDGAR →Monroe Capital Income Plus Corp issued 1,145,836 shares of common stock at $9.77 per share for an aggregate offering price of $11.2 million pursuant to subscription agreements, with the sale exempt from registration under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →The Company sold 1,677,806 unregistered shares of common stock for approximately $33.4 million pursuant to subscription agreements with investors, exempt from registration under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →Blue Owl Real Estate Net Lease Trust sold 2,139,619 shares of Class I common shares to feeder vehicles for approximately $22.9 million in gross proceeds, with the offering exempt from registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →Blue Owl Digital Infrastructure Trust sold 12,470,870 common shares for approximately $131.7 million in gross proceeds on July 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from registration.
View raw filing on EDGAR →Vision Marine completed an at-the-market (ATM) equity offering program that raised approximately US$16.3 million in gross proceeds through the issuance of 6,380,235 common shares, bringing total outstanding shares to 6,530,460.
View raw filing on EDGAR →VivoSim Labs entered into a Securities Purchase Agreement on July 16, 2026, to issue pre-funded warrants and common warrants to purchase up to 4,705,883 shares of common stock at $0.85 per share for approximately $4.0 million in gross proceeds. The unregistered securities are issued under Section 4(a)(2) and Regulation D exemptions, with the company agreeing to file a registration statement for resale. The transaction includes amendment of existing Armistice warrants downward from $9.60 to $0.85 per share, creating substantial warrant overhang and dilution to existing shareholders.
View raw filing on EDGAR →LAGO Evergreen Credit disclosed an unregistered sale of 666,496 common shares at $25.37 per share for an aggregate purchase price of $16.9 million to accredited investors in a private placement. The transaction is explicitly exempt under Section 4(a)(2) of the Securities Act and Regulation D, which are the standard exemptions for private placements. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →The 6-K discloses entry into a Securities Purchase Agreement on July 17, 2026, for a private placement of 5,333,331 Class A ordinary shares and 5,333,331 warrants to non-U.S. persons at $0.30 per share/warrant, generating approximately $1.6 million in gross proceeds. This is a classic dilutive equity issuance under Regulation S, material to investors as it increases share count and dilutes existing shareholders' ownership.
View raw filing on EDGAR →The 6-K discloses a private placement of 7,000,000 Class A ordinary shares at US$1.552 per share for a total of US$10,864,000, completed on July 17, 2026. The shares were issued pursuant to Section 4(a)(2) of the Securities Act and Regulation D/S, which are classic exemptions for unregistered equity issuances. This is a material dilutive equity offering that would affect a reasonable investor's assessment of ownership and capital structure.
View raw filing on EDGAR →Sadot Group issued 200,000 shares of Common Stock and 3,950 shares of Series C Preferred Stock to the seller as acquisition consideration, plus convertible notes and additional shares under an Equity Purchase Facility Agreement, all offered under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →The exhibit discloses an underwritten offering of 10,309,280 common shares at US$4.85 per share for aggregate gross proceeds of US$50 million, closed on June 25, 2026. This is a registered public offering of equity securities under Form F-10 (a multijurisdictional disclosure system filing), not an unregistered private placement. However, the core event—issuance of a substantial number of new common shares to raise capital—is a dilutive equity issuance material to investors. The offering was announced June 24 and closed June 25, 2026, with proceeds intended for clinical development programs (HLP003, HLP004, HLP005) and working capital.
View raw filing on EDGAR →Cardiff Oncology completed a registered direct offering of approximately 8.6 million shares of common stock and accompanying warrants at $1.05 per share, with officers and directors purchasing an additional ~731,707 insider shares at $1.435 per share, generating approximately $10.05 million in gross proceeds for working capital and general corporate purposes.
View raw filing on EDGAR →The filing discloses an unregistered sale of 194,814 common shares of beneficial interest to accredited investors in a private placement for $6.74 million, exempt under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance that increases share count and raises capital, materially affecting existing shareholders' ownership percentages and the registrant's capital structure.
View raw filing on EDGAR →Mercator Acquisition Corp. completed a private placement of 4,500,000 warrants to the Sponsor and Underwriter at $1.00 per warrant, generating $4.5 million in gross proceeds pursuant to Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →Concurrent with the Kira Pharmaceuticals acquisition, Jasper Therapeutics completed a $132 million PIPE offering of approximately 4.7 million shares of unregistered preferred stock to accredited investors under Section 4(a)(2) and Regulation D. PIPE investors are expected to own approximately 43.46% of the combined company on a fully diluted basis.
View raw filing on EDGAR →LGL Group announced preliminary results of a transferable subscription rights offering that generated approximately $41.7 million in gross proceeds through the issuance of 6,042,031 shares of common stock at $6.90 per share. This is a material dilutive equity issuance that increases the company's capital base and shareholder count, affecting existing shareholders' ownership percentages and earnings per share.
View raw filing on EDGAR →Green Circle entered into a securities purchase agreement on July 16, 2026, to issue unsecured promissory notes (US$10M principal, US$8M subscription price) and common warrants exercisable for up to 29.1 million ordinary shares at US$2.00 per share. The offering is exempt from Securities Act registration and represents a significant dilutive issuance of equity warrants and convertible debt instruments to raise capital.
View raw filing on EDGAR →